Entero Healthcare Solutions
add_icon

Entero Healthcare Solutions

1,106.60
+0.80
(0.07%)
Market Cap
4,814.92 Cr
PE Ratio
36.50
Volume
73,808.00
Day High - Low
1,151.50 - 1,092.00
52W High-Low
1,510.80 - 944.00
ann
Q3 Quarterly Results are out. Check out the updated financials1 day ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
4,814.92 Cr
EPS
21.80
PE Ratio
36.50
PB Ratio
2.73
Book Value
383.85
EBITDA
211.10
Dividend Yield
0.00 %
Industry
Retail
Return on Equity
6.07
Debt to Equity
0.22
Analyst Rating and Forecast
- By Refinitiv from3 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Entero Healthcare Solutions reported Q3FY26 standalone revenue of ₹1,067.36 million, up from ₹1,011.52 million in Q3FY25. However, net profit declined to ₹8.05 million from ₹107.83 million due to exceptional items worth ₹44.97 million related to new labour codes.
positive
Entero Healthcare Solutions Limited has successfully completed the acquisition of a majority 51.51% equity stake in Anand Chemiceutics Private Limited, as announced in regulatory filing.
neutral
Entero Healthcare Solutions announces earnings call on February 07, 2026 to discuss Q3FY26 financial results with analysts and investors, hosted by DAM Capital Advisors.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
846.65
#1 10,144.78
49.28
#1 6,184.70
9.18
#1 150
#1 25.93
52.23
1,106.60
#2 4,814.92
#2 36.50
#2 5,135.30
#2 30.45
#2 107
#2 14.92
45.19
64.45
128.50
-
9.20
-4.17
-2
-166.67
61.05
58.80
114.83
#1 22.78
117.90
#1 99.16
5
-
60.81

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
30.45 %
Net Income Growth
169.85 %
Cash Flow Change
-109.97 %
ROE
150.83 %
ROCE
67.13 %
EBITDA Margin (Avg.)
28.04 %

Quarterly Financial Results

Quarterly Financials
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
832
888
901
998
994
1,043
1,111
1,312
1,367
1,346
1,410
1,576
1,711
Expenses
810
867
873
968
964
1,005
1,067
1,258
1,309
1,290
1,354
1,509
1,647
EBITDA
21
21
27
31
30
38
44
54
58
56
56
67
64
Operating Profit %
2 %
2 %
3 %
3 %
3 %
3 %
3 %
3 %
4 %
4 %
4 %
4 %
3 %
Depreciation
5
7
6
6
6
7
7
8
8
9
9
10
10
Interest
13
13
14
18
16
17
10
12
10
11
11
12
14
Profit Before Tax
3
1
7
7
8
14
27
35
39
37
36
45
40
Tax
-1
5
0
2
1
-8
7
9
10
6
6
8
7
Net Profit
4
-4
6
5
7
21
21
26
30
31
30
37
34
EPS in ₹
8.67
1.49
15.18
3.24
4.21
5.73
4.62
5.43
5.85
5.91
6.39
7.26
6.35

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
749
836
1,126
1,309
2,345
2,703
Fixed Assets
186
189
262
268
289
559
Current Assets
552
636
851
1,023
2,011
2,076
Capital Work in Progress
2
2
1
0
0
0
Investments
0
0
0
0
0
58
Other Assets
561
645
863
1,041
2,056
2,085
Total Liabilities
749
836
1,126
1,309
2,345
2,703
Current Liabilities
269
291
462
624
602
845
Non Current Liabilities
56
58
101
87
102
87
Total Equity
424
487
563
598
1,641
1,770
Reserve & Surplus
-16
-32
-62
-73
1,593
1,676
Share Capital
439
517
4
4
44
44

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
-23
-11
14
-21
122
82
Investing Activities
-203
-31
-162
-49
-704
232
Operating Activities
-37
-69
-35
-45
-37
-77
Financing Activities
217
89
211
73
863
-74

Share Holding

% Holding
Sept 2023
Feb 2024
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
78.85 %
52.44 %
52.44 %
52.44 %
52.44 %
52.44 %
52.42 %
52.42 %
52.42 %
52.42 %
FIIs
0.00 %
0.00 %
23.30 %
23.32 %
23.82 %
22.21 %
19.92 %
17.20 %
14.67 %
5.14 %
DIIs
0.00 %
1.36 %
2.28 %
2.06 %
7.73 %
8.77 %
9.64 %
10.18 %
9.65 %
16.42 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
5.72 %
4.95 %
5.00 %
4.06 %
4.36 %
5.41 %
6.99 %
9.36 %
11.56 %
Others
21.15 %
40.48 %
17.03 %
17.18 %
11.95 %
12.23 %
12.61 %
13.20 %
13.90 %
14.46 %
No of Share Holders
51
58
80,864
66,400
36,767
33,172
33,159
33,338
36,334
40,333

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
28 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
28 Aug 2024 1,245.00 1,301.20
12 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2024 1,387.70 1,477.80
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 1,372.25 1,328.65
27 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 May 2025 1,443.60 1,477.30
08 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Aug 2025 1,265.95 1,257.25
18 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
18 Sept 2025 1,158.70 1,132.30
12 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2025 1,111.35 1,089.00
12 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2026 1,131.80 1,148.70

Announcements

Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025 With UDIN5 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome5 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication5 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation5 days ago
Announcement under Regulation 30 (LODR)-Monitoring Agency Report5 days ago
Intimation For Grant Of Fresh 5000 ESOP6 days ago
Submission Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31 20256 days ago
Board Meeting Outcome for Outcome Of The Board Meeting Held On February 12 20266 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release9 days ago
Update On AcquisitionFeb 07, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 06, 2026
Board Meeting Intimation for Approval Of The Financial Results For The Quarter Ended December 31 2025Feb 03, 2026
Disclosure Pursuant To Regulation 30 Of SEBI (LODR) Regulations 2015.Jan 27, 2026
Change Of Name Of M/S. M S K A & Associates Chartered Accountants Statutory Auditor Of The Company - Upon Conversion Of Firm Into LLPJan 15, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 31, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Dec 31, 2025
Closure of Trading WindowDec 23, 2025
Intimation For Grant Of 73060Options Pursuant To "Entero Employees Stock Options Plan 2023" To The Eligible Employees Of The CompanyDec 06, 2025
Announcement under Regulation 30 (LODR)-Credit RatingDec 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 27, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 20, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 13, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 12, 2025
Announcement under Regulation 30 (LODR)-AcquisitionNov 12, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementNov 12, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportNov 12, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 12, 2025
Submission Of Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025Nov 12, 2025
Board Meeting Outcome for Outcome Of Board Meeting Dated November 12 2025Nov 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 07, 2025
Board Meeting Intimation for Approval Of The Financial Results For The Quarter Ended September 30 2025Oct 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 03, 2025
Announcement under Regulation 30 (LODR)-Diversification / DisinvestmentSep 29, 2025
Announcement under Regulation 30 (LODR)-AcquisitionSep 29, 2025
Board Meeting Outcome for Outcome Of Board MeetingSep 29, 2025
Closure of Trading WindowSep 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 18, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 18, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 18, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 10, 2025
Announcement under Regulation 30 (LODR)-Change in Corporate Office AddressSep 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 26, 2025
General UpdatesAug 25, 2025

Technical Indicators

RSI(14)
Neutral
43.27
ATR(14)
Volatile
57.10
STOCH(9,6)
Neutral
49.79
STOCH RSI(14)
Neutral
49.24
MACD(12,26)
Bearish
-5.24
ADX(14)
Weak Trend
21.83
UO(9)
Bearish
41.86
ROC(12)
Downtrend And Accelerating
-0.66
WillR(14)
Neutral
-71.76